PFE Moad et Chamess vf

42 Trac J, Keck JM, Deweese JE. Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review. J Cannabis Res. 2021 Apr 23;3(1):11. doi: 10.1186/s42238- 021-00067-z. PMID: 33892826; PMCID: PMC8067350. Uchiyama N, Kikura-Hanajiri R, Goda Y. Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB1 and CB2 receptors. Chem Pharm Bull (Tokyo). 2011;59(9):1203-5. doi: 10.1248/cpb.59.1203. PMID: 21881274. Wiley JL, Marusich JA, Huffman JW. Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids. Life Sci. 2014 Feb 27;97(1):55-63. doi: 10.1016/j.lfs.2013.09.011. Epub 2013 Sep 23. PMID: 24071522; PMCID: PMC3944940. Walsh, K.B.; Andersen, H.K. Molecular Pharmacology of Synthetic Cannabinoids: Delineating CB1 Receptor-Mediated Cell Signaling. Int. J. Mol. Sci. 2020, 21, 6115. https://doi.org/10.3390/ijms21176115. Ware, M. A., & Tawfik, V. L. (2005). Safety issues concerning the medical use of cannabis and cannabinoids. Pain Research and Management, 10(Suppl A), 31A-37A. Zagožen, M., Čerenak, A., & Kreft, S. (2021). Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharmaceutica, 71(3), 355-364. Webographie http://agence-prd.ansm.sante.fr/php/ecodex/notice/N0242579.htm#:~:text=Utilisez%20Sative x%20uniquement%20par%20voie,m%C3%A9dicament%20que%20votre%20organisme%20 re%C3%A7oit. Consulte le 15/04/2023 http://agence-prd.ansm.sante.fr/php/ecodex/notice/N0242579.htm#:~:text=Utilisez%20Sative x%20uniquement%20par%20voie,m%C3%A9dicament%20que%20votre%20organisme%20 re%C3%A7oit. consulte le 15/04/2023